Company Filing History:
Years Active: 2020
Title: Anke Wittmann: Innovator in Fatty Acid Therapeutics
Introduction
Anke Wittmann is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of biochemistry, particularly in the therapeutic applications of omega-3 and omega-6 fatty acids. Her innovative work addresses critical health issues related to impaired sphingolipid metabolism.
Latest Patents
Anke Wittmann holds a patent for her invention titled "Omega-3 and/or omega-6 fatty acid(s) in impaired sphingolipid metabolism." This patent focuses on the application of omega-3 and/or omega-6 fatty acids for therapeutic treatment in cases of impaired sphingolipid metabolism. The invention is particularly relevant for conditions involving defective formation of sphingomyelin synthase enzymes, specifically sphingomyelin synthase 1 and 2. The application has shown promise in treating defects associated with the sphingomyelin synthase 1 and 2 genes. The omega-3 and/or omega-6 fatty acids utilized in her research include polyunsaturated varieties such as EPA, DHA, DPA, ETA, 21:5n3, and SDA.
Career Highlights
Anke Wittmann is affiliated with K.D. Pharma Bexbach GmbH, where she continues to advance her research and development efforts. Her work has garnered attention for its potential to improve therapeutic outcomes for patients with specific metabolic disorders.
Collaborations
Anke collaborates with notable colleagues, including Tobias Hartmann and Marcus Otto Walter Grimm. Their combined expertise enhances the research and development initiatives at K.D. Pharma Bexbach GmbH.
Conclusion
Anke Wittmann's innovative contributions to the field of fatty acid therapeutics highlight her role as a leading inventor in biochemistry. Her patent on omega-3 and omega-6 fatty acids represents a significant advancement in addressing metabolic disorders.